Feasibility of intravoxel incoherent motion diffusion-weighted imaging in distinguishing adenocarcinoma originated from uterine corpus or cervix

[1] Pimenta JM(2013)Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination BMC CANCER 13 553-105

[2] Galindo C(2000)The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States–a 24-year population-based study GYNECOL ONCOL 78 97-3961

[3] Jenkins D(2018)Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome CANCER MANAG RES 10 3955-146

[4] Smith HO(2010)Adenocarcinoma: A unique cervical cancer GYNECOL ONCOL 116 140-1108

[5] Tiffany MF(2016)Endometrial cancer LANCET 387 1094-173

[6] Qualls CR(2003)Endocervical glandular lesions: controversial aspects and ancillary techniques J CLIN PATHOL 56 164-792

[7] Guo P(2011)The value of MR imaging when the site of uterine cancer origin is uncertain RADIOLOGY 258 785-1006

[8] Liu P(2002)Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas AM J SURG PATHOL 26 998-384

[9] Yang J(2013)Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors INT J GYNECOL CANCER 23 380-423

[10] Gien LT(2008)Application of immunohistochemistry to gynecologic pathology ARCH PATHOL LAB MED 132 402-S92

[1] Pimenta JM(2013)Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination BMC CANCER 13 553-105

[2] Galindo C(2000)The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States–a 24-year population-based study GYNECOL ONCOL 78 97-3961

[3] Jenkins D(2018)Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome CANCER MANAG RES 10 3955-146

[4] Smith HO(2010)Adenocarcinoma: A unique cervical cancer GYNECOL ONCOL 116 140-1108

[5] Tiffany MF(2016)Endometrial cancer LANCET 387 1094-173

[6] Qualls CR(2003)Endocervical glandular lesions: controversial aspects and ancillary techniques J CLIN PATHOL 56 164-792

[7] Guo P(2011)The value of MR imaging when the site of uterine cancer origin is uncertain RADIOLOGY 258 785-1006

[8] Liu P(2002)Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas AM J SURG PATHOL 26 998-384

[9] Yang J(2013)Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors INT J GYNECOL CANCER 23 380-423

[10] Gien LT(2008)Application of immunohistochemistry to gynecologic pathology ARCH PATHOL LAB MED 132 402-S92